ATC Abstracts

American Transplant Congress abstracts

2016 American Transplant Congress » Concurrent Session: Kidney AMR: Predicting the Patient at Risk

Date: Tuesday, June 14, 2016

Time: 2:30pm-4:00pm

Location: Ballroom B

Session Type: Concurrent Session

Meeting: 2016 American Transplant Congress

2:30pm-2:42pm
Is C3d-fixing Donor Specific HLA Antibody Detection Really Necessary?

P. Malvezzi,1 M. Villemaire,1 A. Bourdin,2 T. Jouve,1 R. Tetaz,1 B. Janbon,1 N. Terrier,3 D. Masson.2

2:42pm-2:54pm
HLA Antibody in Transplant Recipients During Transition from Paediatrics.

S. Kaki,1 A. Lunn,2 J. Goodwin,3 T. Key,3 W. McKane.1

2:54pm-3:06pm
DSA After Transplant Increases Risk of Renal Allograft Failure Independent of Concurrent Biopsy Results: The DEKAF Study Data.

J. Cecka,1 J. Grande,2 F. Cosio,2 R. Leduc,3 The DeKAF Study Group.

3:06pm-3:18pm
Immunogenic HLA-DR Eplet Mismatches as Predictors of Transplant Glomerulopathy.

D. Blum,1 K. Tinckam,2 M. Marrari,3 J. Kim,2 R. Sapir-Pichhadze.1

3:18pm-3:30pm
Association of Ultrastructural Changes in Renal Allograft Biopsies with Antibody-Mediated Rejection (AMR) and Graft Outcomes.

A. Haririan,1 M. Chaudhry,2 J. Papadimitriou,2 N. Costa,1 B. Thomas,1 M. Mavanur,1 R. Ugarte,1 C. Cangro,1 C. Drachenberg.2

3:30pm-3:42pm
Antibody Mediated Rejection and Mixed Acute Rejection: Long Term Results and Predictive Factors for Graft Loss Following Proteasome Inhibitor Therapy.

A. Lichvar,1 A. Leino,1 S. Tremblay,1 B. Abu-Jawdeh,1 A. Govil,1 G. Mogilishetty,1 M. Cardi,2 J. Kremer,2 M. Cuffy,1,2 F. Paterno,1 A. Shields,1,2 D. Witte,1 R. Alloway,1 E. Woodle.1

3:42pm-3:54pm
Evaluation of the Toxicity Profile of Proteasome Inhibitor-Based Therapy for Antibody Mediated Rejection.

A. Leino,1 A. Lichvar,1 B. Abu-Jawdeh,1 A. Govil,1 G. Mogilishetty,1 M. Cardi,2 J. Kremer,2 M. Cuffy,1 F. Paterno,1 R. Alloway,1 A. Shields,1,2 E. Woodle.1

« View all sessions from the 2016 American Transplant Congress